医薬品リファレンス
Daraxonrasib
Daraxonrasib is a medicine in the class oncology. It is used for pancreatic cancer.
- 薬効分類: Oncology
- 効能・効果: pancreatic cancer
最終更新日 出典: US FDA label
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Oncology
- 一般的な剤形
- 錠剤
- 商品名
- 1
- 国・市場
- 1
何に使われるか
作用のしくみ
Inhibitor of the RAS GTPase family. It binds cyclophilin A, and the resulting complex binds active GTP-bound RAS, blocking downstream effector interactions and promoting GTP hydrolysis to inactive GDP-bound RAS.
成人の通常用量（添付文書の要約）
Metastatic pancreatic adenocarcinoma (after at least one prior systemic therapy or not a candidate for multiagent therapy): 300 mg orally once daily at the same time each day, with or without food, until disease progression or unacceptable toxicity
妊娠と授乳
- 妊娠
- Unsafe Can cause fetal harm: in mice it caused fetal death, growth changes and malformations at exposures 2.5 times the human dose; no human data. Avoid in pregnancy; check pregnancy status before starting and use effective contraception during treatment and for 1 week after the last dose.
- 授乳
- Unsafe No data on milk levels or infant effects. Because of possible serious reactions in the infant, do not breastfeed during treatment and for 1 week after the last dose.
報告されている副作用
- Rash
- Diarrhea
- Stomatitis
- Nausea
- Fatigue
- Vomiting
注意が必要な方
- Dermatologic and soft tissue toxicity (rash, pruritus, paronychia, dry skin), which may be severe. Use prophylaxis before the first dose and limit sun exposure.
- Stomatitis and oral disorders, including mouth ulcers and oral mucositis. Monitor and treat with a steroid-containing mouthwash.
- Diarrhea: give antidiarrheal treatment as clinically indicated, and withhold, reduce or discontinue based on severity.
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Daraxonrasibの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
WebでPro+を14日間無料でお試し。カード登録不要。
よくある質問
What is Daraxonrasib used for?
Daraxonrasib is a medicine in the class oncology. It is used for Pancreatic cancer.
What side effects have been reported with Daraxonrasib?
Rash, Diarrhea, Stomatitis, Nausea, Fatigue, Vomiting.
Can Daraxonrasib be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm: in mice it caused fetal death, growth changes and malformations at exposures 2.5 times the human dose; no human data. Avoid in pregnancy; check pregnancy status before starting and use effective contraception during treatment and for 1 week after the last dose. Breastfeeding: Unsafe. No data on milk levels or infant effects. Because of possible serious reactions in the infant, do not breastfeed during treatment and for 1 week after the last dose.
What does Daraxonrasib interact with?
MediHelp does not list a checked interaction for Daraxonrasib yet. Always tell your pharmacist about every medicine you take.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
